MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies SE Ahmadi, S Rahimi, B Zarandi, R Chegeni, M Safa Journal of hematology & oncology 14, 1-49, 2021 | 116 | 2021 |
Worldwide prevalence of microbial agents’ coinfection among COVID‐19 patients: A comprehensive updated systematic review and meta‐analysis R Pakzad, P Malekifar, Z Shateri, M Zandi, S Akhavan Rezayat, ... Journal of Clinical Laboratory Analysis 36 (1), e24151, 2022 | 31 | 2022 |
Viral vectors and extracellular vesicles: Innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy SE Ahmadi, M Soleymani, F Shahriyary, MR Amirzargar, M Ofoghi, ... Cancer Gene Therapy 30 (7), 936-954, 2023 | 21 | 2023 |
Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment M Valikhani, E Rahimian, SE Ahmadi, R Chegeni, M Safa Experimental Hematology & Oncology 10, 1-26, 2021 | 20 | 2021 |
The prognostic importance of BCR-ABL transcripts in chronic myeloid leukemia: a systematic review and meta-analysis OK Ghalesardi, A Khosravi, E Azizi, SE Ahmadi, A Hajifathali, H Bonakchi, ... Leukemia Research 101, 106512, 2021 | 18 | 2021 |
Molecular basis of rare congenital bleeding disorders A Dorgalaleh, M Bahraini, M Shams, F Parhizkari, A Dabbagh, T Naderi, ... Blood reviews 59, 101029, 2023 | 16 | 2023 |
Pooled prevalence estimate of ocular manifestations in COVID-19 patients: a systematic review and meta-analysis S Soltani, M Zandi, SE Ahmadi, B Zarandi, Z Hosseini, SA Rezayat, ... Iranian journal of medical sciences 47 (1), 2, 2022 | 16 | 2022 |
Detection of aflatoxin M1 in milk from Qom (aried and semiaried) province of Iran M Dakhili, S Shalibeik, I Ahmadi International Journal of Advanced Biotechnology and Research 7 (3), 1461-1465, 2016 | 9 | 2016 |
A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism V Takhviji, K Zibara, A Maleki, E Azizi, S Hommayoun, M Tabatabaei, ... Thrombosis Journal 19, 1-9, 2021 | 6 | 2021 |
Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients M Paridar, K Zibara, SE Ahmadi, A Khosravi, M Soleymani, E Azizi, ... Molecular Cytogenetics 14 (1), 24, 2021 | 6 | 2021 |
Congenital combined bleeding disorders, a comprehensive study of a large number of Iranian patients SE Ahmadi, M Jazebi, G Bahoush, MR Baghaipour, F Ala, S Tabibian Clinical and Applied Thrombosis/Hemostasis 27, 1076029621996813, 2021 | 5 | 2021 |
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer SE Ahmadi, A Shabannezhad, A Kahrizi, A Akbar, SM Safdari, ... Biomarker Research 11 (1), 60, 2023 | 4 | 2023 |
Personalized anesthesia in hematology A Dorgalaleh, M Bahraini, SE Ahmadi Personalized medicine in anesthesia, pain and perioperative medicine, 231-274, 2021 | 4 | 2021 |
Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors M Pakjoo, SE Ahmadi, M Zahedi, N Jaafari, R Khademi, A Amini, M Safa Cell Communication and Signaling 22 (1), 105, 2024 | 1 | 2024 |
A straightforward microfluidic-based approach toward optimizing transduction efficiency of HIV-1-derived lentiviral vectors in BCP-ALL cells SE Ahmadi, RM Shabestari, M Safa Biotechnology Reports 38, e00792, 2023 | 1 | 2023 |